Combining behavioral therapies to help smokers with HIV quit in Botswana
Testing the Combination of Behavioral Activation and Problem Solving as a Novel Behavioral Smoking Cessation Intervention for Smokers with HIV in Botswana
['FUNDING_R01'] · UNIVERSITY OF PENNSYLVANIA · NIH-10978303
This study is testing a new way to help people with HIV in Botswana quit smoking by using two supportive methods that encourage healthy activities and tackle feelings of depression, making it easier for them to stop smoking for good.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10978303 on ClinicalTrials.gov |
What this research studies
This research investigates a new approach to help individuals with HIV in Botswana quit smoking by combining two behavioral therapies: behavioral activation and problem-solving. The study recognizes the unique challenges faced by HIV-positive smokers, such as high rates of depression and limited access to pharmacotherapy. By focusing on increasing engagement in healthy activities and addressing depressive symptoms, the research aims to create a feasible smoking cessation intervention tailored for this population. Participants will receive support to develop problem-solving skills alongside behavioral activation techniques to improve their chances of quitting smoking.
Who could benefit from this research
Good fit: Ideal candidates for this research are HIV-positive individuals in Botswana who smoke and may also experience depressive symptoms.
Not a fit: Patients who do not smoke or are not HIV-positive may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve smoking cessation rates among HIV-positive individuals in Botswana, leading to better health outcomes.
How similar studies have performed: Previous research has shown promise in using behavioral activation for smoking cessation, particularly in populations with comorbid conditions, suggesting this approach may be effective.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GROSS, ROBERT — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: GROSS, ROBERT
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.